BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37642304)

  • 21. Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.
    Esser LK; Branchi V; Shakeri F; Simon AG; Stephan C; Kristiansen G; Buness A; Schorle H; Toma MI
    Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35059737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-expressed CKS2 is associated with hepatocellular carcinoma cell proliferation through down-regulating PTEN.
    Ji X; Xue Y; Wu Y; Feng F; Gao X
    Pathol Res Pract; 2018 Mar; 214(3):436-441. PubMed ID: 29487004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
    Yu K; Ji Y; Liu M; Shen F; Xiong X; Gu L; Lu T; Ye Y; Feng S; He J
    Front Immunol; 2022; 13():881453. PubMed ID: 35663965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
    Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
    Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer.
    Jonsson M; Fjeldbo CS; Holm R; Stokke T; Kristensen GB; Lyng H
    Neoplasia; 2019 Apr; 21(4):353-362. PubMed ID: 30856376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells.
    Martinsson-Ahlzén HS; Liberal V; Grünenfelder B; Chaves SR; Spruck CH; Reed SI
    Mol Cell Biol; 2008 Sep; 28(18):5698-709. PubMed ID: 18625720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
    Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
    Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
    Chen M; Zhao Z; Wu L; Huang J; Yu P; Qian J; Ni T; Zhao C
    Cell Death Dis; 2022 Sep; 13(9):784. PubMed ID: 36096885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
    Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
    J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
    Kang MA; Kim JT; Kim JH; Kim SY; Kim YH; Yeom YI; Lee Y; Lee HG
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):761-9. PubMed ID: 19034516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.
    Feng J; Hu M; Li Z; Hu G; Han Y; Zhang Y; Zhang M; Ren J
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
    Xiao D; Johnson CS; Trump DL; Singh SV
    Mol Cancer Ther; 2004 May; 3(5):567-75. PubMed ID: 15141014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KLF8 knockdown triggered growth inhibition and induced cell phase arrest in human pancreatic cancer cells.
    Yi X; Li Y; Zai H; Long X; Li W
    Gene; 2016 Jul; 585(1):22-27. PubMed ID: 26995652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of hub genes in chronic pancreatitis and analysis of association with pancreatic cancer via bioinformatic analysis.
    Li H; Hao C; Yang Q; Gao W; Ma B; Xue D
    Gen Physiol Biophys; 2022 Jan; 41(1):15-30. PubMed ID: 35253647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
    Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods.
    Gao L; Chen G; Liang ZQ; Li JD; Li DM; Tang YL; Tang D; Huang ZG; Chen JH; Luo JY; Zeng JH; Dang YW; Feng ZB
    Pathol Oncol Res; 2022; 28():1610307. PubMed ID: 35693634
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
    Zhang Y; Li Z; Huang Y; Zou B; Xu Y
    BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
    Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
    Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells.
    Lin L; Fang Z; Lin H; You H; Wang J; Su Y; Wang F; Zhang ZY
    Oncol Rep; 2016 Jan; 35(1):26-32. PubMed ID: 26531156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.